These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11740160)

  • 41. Can we prevent recurrences of herpes infections without antiviral drugs? The Weisenfeld Lecture.
    Kaufman HE
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1325-9. PubMed ID: 11980842
    [No Abstract]   [Full Text] [Related]  

  • 42. The virion host shutoff function of herpes simplex virus type 1 plays a role in corneal invasion and functions independently of the cell cycle.
    Strelow L; Smith T; Leib D
    Virology; 1997 Apr; 231(1):28-34. PubMed ID: 9143299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrent ocular herpes simplex keratitis following excimer laser photorefractive keratectomy in a rabbit model.
    Epstein SP; Fisher EM; Sternberg GJ; Franklin W; Gordon R; Ho JJ; Asbell PA
    CLAO J; 2001 Apr; 27(2):94-9. PubMed ID: 11352456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Herpes simplex keratitis.
    Kaye S; Choudhary A
    Prog Retin Eye Res; 2006 Jul; 25(4):355-80. PubMed ID: 16807055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycoprotein C of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneas.
    Drolet BS; Mott KR; Lippa AM; Wechsler SL; Perng GC
    Curr Eye Res; 2004; 29(2-3):181-9. PubMed ID: 15512965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation.
    Gebhardt BM; Varnell ED; Kaufman HE
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):114-20. PubMed ID: 15857277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [An experimental study on HSV-1 corneal latency by in situ nucleic acid hybridization].
    Li S; Xie L; Dong X
    Zhonghua Yan Ke Za Zhi; 1995 Sep; 31(5):366-9. PubMed ID: 8706587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Herpes simplex virus type 1 latency and reactivation: an update].
    Aranda AM; Epstein AL
    Med Sci (Paris); 2015 May; 31(5):506-14. PubMed ID: 26059301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency.
    Divito S; Cherpes TL; Hendricks RL
    Immunol Res; 2006; 36(1-3):119-26. PubMed ID: 17337772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atypical herpetic keratitis presenting as multifocal epithelial lesions.
    Galvis V; Tello A
    Biomedica; 2020 Dec; 40(4):585-586. PubMed ID: 33275335
    [No Abstract]   [Full Text] [Related]  

  • 51. Clues to mechanisms of herpesviral latent infection and potential cures.
    Knipe DM; Raja P; Lee JS
    Proc Natl Acad Sci U S A; 2015 Sep; 112(39):11993-4. PubMed ID: 26392531
    [No Abstract]   [Full Text] [Related]  

  • 52. Keratitis due to Colletotrichum gloeosporioides and Herpesvirus reactivation.
    Borrás-Máñez M; Ortega-Evangelio L; Gil-Tomás JJ; Tomás JM
    Enferm Infecc Microbiol Clin; 2016 Jan; 34(1):69-70. PubMed ID: 26093958
    [No Abstract]   [Full Text] [Related]  

  • 53. 2015 Colorado Alphaherpesvirus Latency Society Symposium.
    Cohrs RJ; Gilden D
    J Neurovirol; 2015 Dec; 21(6):706-16. PubMed ID: 26506840
    [No Abstract]   [Full Text] [Related]  

  • 54. 2016 Colorado alphaherpesvirus latency society symposium.
    Cohrs RJ; Gilden D
    J Neurovirol; 2016 Oct; 22(5):703-714. PubMed ID: 27405986
    [No Abstract]   [Full Text] [Related]  

  • 55. 2017 Colorado alphaherpesvirus latency society symposium.
    Baird NL; Cohrs RJ
    J Neurovirol; 2017 Aug; 23(4):642-655. PubMed ID: 28786028
    [No Abstract]   [Full Text] [Related]  

  • 56. Suppression of herpes simplex virus 1 reactivation in a mouse eye model by cyclooxygenase inhibitor, heat shock protein inhibitor, and adenosine monophosphate.
    Shimomura Y; Higaki S; Watanabe K
    Jpn J Ophthalmol; 2010 May; 54(3):187-90. PubMed ID: 20577849
    [No Abstract]   [Full Text] [Related]  

  • 57. Reactivation and latency of herpesvirus in the eye.
    Shimomura Y
    Ophthalmologica; 2001; 215 Suppl 2():15-24; discussion, 40-1. PubMed ID: 11740160
    [No Abstract]   [Full Text] [Related]  

  • 58. Ocular HSV-1 latency, reactivation and recurrent disease.
    Toma HS; Murina AT; Areaux RG; Neumann DM; Bhattacharjee PS; Foster TP; Kaufman HE; Hill JM
    Semin Ophthalmol; 2008; 23(4):249-73. PubMed ID: 18584563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sodium butyrate: a chemical inducer of in vivo reactivation of herpes simplex virus type 1 in the ocular mouse model.
    Neumann DM; Bhattacharjee PS; Hill JM
    J Virol; 2007 Jun; 81(11):6106-10. PubMed ID: 17360760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Large Amounts of Reactivated Virus in Tears Precedes Recurrent Herpes Stromal Keratitis in Stressed Rabbits Latently Infected with Herpes Simplex Virus.
    Perng GC; Osorio N; Jiang X; Geertsema R; Hsiang C; Brown D; BenMohamed L; Wechsler SL
    Curr Eye Res; 2016; 41(3):284-91. PubMed ID: 25859798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.